# Does initial high efficacy therapy in multiple sclerosis surpass escalation treatment strategy? A comparison of patients with relapsing-remitting multiple sclerosis in the Czech and Swedish national multiple sclerosis registries

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/does-initial-high-efficacy-therapy-in-multiple-sclerosis-surpass-escalation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Tereza Hrnčiarová,Jiří Drahota,Tim Spelman,Jan Hillert,Jan Lycke,Eva Havrdová,Eva Recmanová,Jana Adámková,Jan Mareš,Jana Libertínová,Zbyšek Pavelek,Pavel Hradílek,Radek Ampapa,Ivana Štětkářová,Marek Peterka,Alena Martinková,Pavel Štourač,Markéta Grünermelová,Marta Vachová,Michal Dufek,Dana Horáková |
| Citations | 19 |
| DOI | 10.1016/j.msard.2023.104803 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4380319232 |
| PMID | 37329786 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Zbyšek Pavelek](https://scholariq.org/researchers/zbysek-pavelek/)

## Paper primary topic

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)

## Paper topics

- [Multiple Sclerosis Research Studies](https://scholariq.org/topics/multiple-sclerosis-research-studies/)
- [Peripheral Neuropathies and Disorders](https://scholariq.org/topics/peripheral-neuropathies-and-disorders/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.